INVESTMENT NEWS SHOW
March 18, 2014
Money Info Show Airs at
10:00 AM to 11:00 AM EDT
The show will feature an interview with:
Andy Sealfon, President & CEO of
RMS Medical Products
(Stock Symbol: REPR)
Visit the corporate website:
NEW — RMS Connections blog shares amazing stories to give a stronger voice to the rare disease community — http://blog.rmsmedicalproducts.com/
RMS Medical Products specializes in developing and manufacturing portable medical devices, understanding that healthcare professionals need products that they can depend on in critical situations – that will work every time. For patients, these products are often profoundly uplifting to their quality of life.
With that in mind, REPR offers products for a wide variety of markets including hospitals, home healthcare, nursing homes and rescue services.
STRONG GROWTH CONTINUES
REPR Annual Revenue and Profits Continue To Increase
Primary products are:
FREEDOM60®Syringe Infusion System – Used for the subcutaneous administration of immune globulin offers safe, controlled pressure and ability to adjust automatically to the flow. The inherently safe pressures used to deliver drugs to patients minimize discomfort, swelling and other complications sometimes found with conventional electric infusion devices. There are additional applications such as the delivery of antibiotics and other drugs.
RES-Q-VAC®Emergency Suction – Fills a niche in emergency medicine, hospitals, and home care for immediate airway suction when and wherever needed. RES-Q-VAC® has patented filtration to minimize exposure of medical personnel to dangerous pathogens from patients infected with life threatening diseases such as tuberculosis and SARS. Because RES-Q-VAC® provides reliable suction without electric power, it is useful in disasters when the electricity fails.
RMS HIGH-Flo™ Subcutaneous Safety Needle Sets – RMS Successfully introduced this product to the US market during the 2012 fiscal year. Used with the Company’s FREEDOM60® pump or pumps from other manufacturers. The Company has received feedback from some SCIG patients experiencing less pain, less infusion time, and less discomfort when switching to High-Flo™.
See more product information at
Where To Invest Your Money Now
REPR Announces Board Changes, Stock Buy-Back Plan — The company intends to purchase up to 1,000,000 shares of its stock on the open market when conditions permit — See News
Use this Link To Watch The Show:
BE ON THE AIR WITH US
CALL IN YOUR QUESTIONS
The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.
Money Info is hosted by Mike King, Charles Moskowitz and Oscar Carboni.